Sec. 562.156.  COMPOUNDED STERILE PREPARATION; NOTICE TO BOARD.  (a)  A pharmacy may not compound and dispense a sterile preparation unless the pharmacy holds a license as required by board rule.
(b)  A pharmacy that compounds a sterile preparation shall notify the board:
(1)  immediately of any adverse effects reported to the pharmacy or that are known by the pharmacy to be potentially attributable to a sterile preparation compounded by the pharmacy; and
(2)  not later than 24 hours after the pharmacy issues a recall for a sterile preparation compounded by the pharmacy.
Added by Acts 2013, 83rd Leg., R.S., Ch. 608 (S.B. 1100), Sec. 6, eff. September 1, 2013.